Mucociliary clearance in cystic fibrosis: Physiology and pharmacological treatments

Paediatrics and Child Health

Volumn 21, Issue 9, 2011, Pages 425-430

  Treacy, Katherine ^a   Tunney, Michael ^a   Elborn, J Stuart ^a   Bradley, Judy M ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Abnormal mucociliary clearance; Cystic fibrosis; Pulmonary pathophysiology

Indexed keywords

AEROQUIN; AMIKACIN; AMILORIDE; ANTIBIOTIC AGENT; ARIKACE; AZTREONAM LYSINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRAMITOB; CIPROFLOXACIN; COLISTIN; COLOBREATH; DENUFOSOL; FOSFOMYCIN; IVACAFTOR; LANCOVUTIDE; LEVOFLOXACIN; MANNITOL; PROMIXIN; TOBRAMYCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

AIRWAY CLEARANCE TECHNIQUE; ANTIBIOTIC THERAPY; BRONCHITIS; CYSTIC FIBROSIS; DRUG FORMULATION; DRUG MECHANISM; GENE MUTATION; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG INFECTION; MUCOCILIARY CLEARANCE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN FUNCTION; RESPIRATORY CARE; REVIEW;

EID: 80051941102     PISSN: 17517222     EISSN: 1878206X     Source Type: Journal    
DOI: 10.1016/j.paed.2011.05.011     Document Type: Review

References (12)

1. Anderson P. Emerging therapies in cystic fibrosis. Ther Adv Respir Dis 2010, 4:177-185.
2. Armstrong D.S., Hook S.M., Jamsen K.M., et al. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol 2005, 40:500-510.
3. Boucher R.C. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med 2007, 58:157-170.
4. Bradley J.M., Moran F.M., Elborn J.S. Evidence for physical therapies (airway clearance and physical training) in cystic fibrosis: an overview of five Cochrane systematic reviews. Respir Med 2006, 100:191-201.
5. Bye P.T., Elkins M.R. Other mucoactive agents for cystic fibrosis. Paediatr Respir Rev 2007, 8:30-39.
6. Courtney J.M., Bradley J., Mccaughan J., et al. Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol 2007, 42:525-532.
7. Frerichs C., Smyth A. Treatment strategies for cystic fibrosis: what's in the pipeline?. Expet Opin Pharmacother 2009, 10:1191-1202.
8. Kreindler J.L. Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies. Pharmacol Therapeut 2010, 125:219-229.
9. O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet 2009, 30:1891-1904.
10. Ratjen F.A. Cystic fibrosis: pathogenesis and future treatment strategies. Respir Care 2009, 54:595-605.
11. Robinson M., Bye P. Mucociliary clearance in cystic fibrosis. Pediatr Pulmonol 2002, 33:293-306.
12. Tunney M.M., Field T.R., Moriarty T.F., et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 2008, 1:995-1001.